Hematology Research Articles & Analysis: Older
2 articles found
Jak/Stat pathway and cancer JAK activating mutations are a major molecular mechanism in malignant hematologic diseases. Researchers have identified a unique somatic mutation (V617F) in the Jak2 pseudokinase domain. ...
At present, 15 ADCs have been approved globally for hematological malignancies and solid tumors. In addition, more than 100 ADC drug candidates are currently under clinical investigation. ...